Honasa Q1 Profit More Than Doubles To ₹90 Cr, Revenue Up 27% YoY

retained text

Mamaearth parent Honasa Consumer’s consolidated net profit more than doubled to ₹90.5 Cr in the quarter ended June 2026 from ₹41.3 Cr in the year-ago period. Net profit grew 30% on a QoQ basis from ₹69.4 Cr. The beauty and personal care company’s operating revenue rose 27% to ₹755.9 Cr from ₹595.3 Cr a year ago. Sequentially, operating revenue increased 15% from ₹657.1 Cr. Including other income of ₹22.5 Cr, Honasa’s total income stood at ₹778.5 Cr during the quarter, up 26% from ₹619.1 Cr in Q1 FY26. The company’s total expenses increased 17% YoY and 11% QoQ to ₹659.3 Cr. Purchase of traded goods rose 41% YoY to ₹240.2 Cr, while employee benefit expenses increased 10% to ₹66.4 Cr. Tax expenses for the quarter stood at ₹28.8 Cr. In a statement, Honasa said that Q1 saw it register its highest-ever quarterly revenue and profit. EBITDA for the quarter also more than doubled to ₹110 Cr from ₹46 Cr in Q1 FY26. The company said a change in the settlement mechanism used by the Flipkart group reduced reported revenue by about ₹29 Cr without affecting its absolute profitability. On a like-for-like basis, Honasa pegged its Q1 FY27 revenue at ₹785 Cr, representing growth of 31.8% YoY. Its EBITDA margin on this basis stood at 14.1%. During the quarter, the company’s focus categories grew more than 35%, while its younger brands recorded growth of over 40%. Honasa said Mamaearth grew in the high teens, while The Derma Co crossed an annualised net sales value run rate of ₹1,000 Cr. Beyond the aforementioned brands, CEO Varun Alagh said that recently acquired brand, Reginald Men, crossed ₹150 Cr ARR and is scaling beyond the South Indian market to new geographies. Other younger brands, Aqualogica, Dr. Sheth's, BBlunt, among others grew 40%. “For me, these are important signals that we are not reliant on any one brand or category; we are building a House of Brands where multiple brands have the potential to scale in their own right using our capabilities and repeatable playbooks. The next phase of this journey is about taking this strength into new categories," Alagh said. In a bid to build its “future-ready House of Brands”, Honasa recently acquired FIKN, India’s first elixir brand, tapping into a large and underpenetrated category. The company announced the acquisition of a majority 58% stake in FIKN parent Fluence Pharma for ₹135 Cr from its existing shareholders at the end of June. Meanwhile, its offline business also expanded during the quarter, with general trade and modern trade growing more than 40%. Honasa’s distribution network crossed 3 Lakh FMCG retail outlets. Shares of Honasa ended today’s trading session 2.84% higher at ₹481.20 apiece on the BSE.

document fetched 2026-08-14 07:32 · canonical https://inc42.com/buzz/honasa-q1-profit-more-than-doubles-to-%e2%82%b990-cr-revenue-up-27-yoy